A real-world analysis of safety profile of selexipag by using FDA adverse Event Reporting System (FAERS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A real-world analysis of safety profile of selexipag by using FDA adverse Event Reporting System (FAERS)

Published:2023-11-30 Issue: Volume: Page:1-12
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Zhao Jie¹,Wang Mei²,Yu Qing¹,Yang Yi³,Zhang Bin⁴,Zhan Sanhua¹

Affiliation:

1. Department of Pharmacy, Tongling People’s Hospital, Tongling, Anhui Province, China

2. Department of Pharmacy, Tongling Sixth People’s Hospital, Tongling, Anhui Province, China

3. Department of Infection, The First Affiliated Hospital Of Anhui Medical University, Hefei, Anhui Province, China

4. Department of Cardiovascular, Tongling People’s Hospital, Tongling, Anhui Province, China

Funder

atural Science Key Project of Bengbu Medical College

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2290633

Reference47 articles.

1. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

2. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

3. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review

4. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

5. Selexipag in Patients With Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of cardiovascular disease drugs approved between 2014 and 2021 in the US: a pharmacovigilance analysis;Expert Review of Cardiovascular Therapy;2024-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3